Opus Genetics, Inc. (Nasdaq: IRD) (the “Company”, “Opus Genetics” or “Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...
12don MSN
There Is No Other Aircraft That Can Do What The C-5 Does – That's Why It Will Fly Until 2050
The USAF plans to keep the C-5M Galaxy flying until 2050 despite low readiness rates, rising costs, and maintenance delays.
This combination of superior execution power and lack of judgment can create a significant challenge for organizations trying ...
Security tooling is not written in a single language. Python powers most automation. C sits at the exploit layer. PowerShell ...
The Trump administration has been scrutinizing the University of California, Berkeley, which insists its new program will be ...
Collaboration will evaluate Scenic's first-in-class PLA2G15 inhibitor program in Parkinson's diseaseLeveraging MJFF’s LITE consortium and ...
Jim Flyzik, who died on June 4 at age 72, played a critical role in this transformation as a long-time IT executive at the Treasury Department and one of the government's first chief information ...
UC Office of the President is launching its AI Buddy Program this month to help its staff members explore and build ...
A federal judge has blocked the Federal administration from enforcing changes to the Public Service Loan Forgiveness program ...
Opus Genetics, Inc. (Nasdaq: IRD) (the "Company", "Opus Genetics" or "Opus"), a clinical-stage biopharmaceutical company developing gene ...
The Treasury Inspector General for Tax Administration found an increase in inventories, from 1.9 million at the beginning of ...
Local author Tiffany Bumgardner is gearing up to release a the first part of a six-part children’s book series. The St.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results